Turkish Thoracic Journal
Review

COVID-19 Treatment at a Glance

1.

Department of Internal Medicine, Intensive Care Unit, Yüzüncü Yıl University, Dursun Odabaş Medical Center, Van, Turkey

2.

Department of Chest Diseases, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey

3.

Department of Chest Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey

4.

Department of Chest Diseases, Ufuk University School of Medicine, Ankara, Turkey

5.

Department of Occupational Health and Diseases, Adana City Research and Training Hospital, Adana, Turkey

6.

Department of Chest Diseases, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey

7.

Department of Chest Diseases, Kütahya University of Health Sciences School of Medicine, Kütahya, Turkey

8.

Department of Pediatric Pulmonology, Gazi University School of Medicine, Ankara, Turkey

9.

Department of Pediatric Pulmonology, Hacettepe University School of Medicine, Ankara, Turkey

10.

Clinic of Chest Diseases, Kırıkhan State Hospital, Hatay, Turkey

11.

Department of Occupational Health and Diseases, Ankara Occupational and Environmental Diseases Hospital, Ankara, Turkey

12.

Department of Chest Diseases, Hacettepe University School of Medicine, Ankara, Turkey

13.

Department of Internal Medicine, Hacettepe University School of Medicine, Unit of Intensive Care, Ankara, Turkey

14.

Clinic of Chest Diseases, Bilecik State Hospital, Bilecik, Turkey

15.

Department of Chest Diseases, Başkent University School of Medicine, Ankara, Turkey

16.

Department of Pediatric Pulmonology, Ankara Training and Research Hospital, Ankara, Turkey

17.

Department of Chest Diseases, Denizli State Hospital, Denizli, Turkey

18.

Department of Chest Diseases, Allergy and Immunology, Uludağ University School of Medicine, Bursa, Turkey

19.

Clinic of Chest Diseases, Ardahan State Hospital Ardahan, Turkey

20.

Department of Pathology, Ankara University, School of Medicine, Ankara, Turkey

21.

Department of Chest Diseases, Kahramanmaraş Afşin State Hospital, Kahramanmaraş, Turkey

22.

Department of Chest Diseases, Düzce University, School of Medicine, Düzce, Turkey

23.

Clinic of Chest Diseases, Siirt State Hospital, Siirt, Turkey

24.

Department of Intensive Care Unit, Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, İzmir, Turkey

25.

Department of Physiotherapy and Rehabilitation, Yeditepe University, School of Health Sciences, İstanbul, Turkey

26.

Department of Nursing, Yeditepe University, School of Health Sciences, İstanbul, Turkey

27.

Department of Chest Diseases, İstanbul Cerrahpasa University, Cerrahpaşa School of Medicine, İstanbul, Turkey

28.

Department of Medical Biology, University of Health Sciences, School of Medicine, İstanbul, Turkey

29.

Department of Chest Diseases, Pamukkale University School of Medicine, Denizli, Turkey

30.

Department of Chest Diseases, Osmangazi University School of Medicine, Eskişehir, Turkey

31.

Clinic of Chest Diseases, Ünye State Hospital, Ordu, Turkey

32.

Department of Chest Diseases, Düzce University School of Medicine, Düzce, Turkey

33.

Department of Chest Diseases, Atatürk University School of Medicine, Erzurum, Turkey

Turk Thorac J 2020; 21: 438-445
DOI: 10.5152/TurkThoracJ.2020.20125
Read: 415 Downloads: 159 Published: 09 December 2020

As coronavirus disease 2019 (COVID-19) spreads across the world, the ongoing clinical trials are leading to a big race worldwide to develop a treatment that will help control the pandemic. Unfortunately, COVID-19 does not have any known effective treatment with reliable study results yet. In this pandemic, there is not a lot of time to develop a new specific agent because of the rapid spread of the disease. The process of developing a vaccine is long and requires hard work. Although the pathophysiology of the disease is not fully understood, some of the proposed treatment alternatives are based on old evidence and some have been used with the idea that they might work owing to their mechanism of action. The efficacy, reliability, and safety of the currently available treatment alternatives are therefore a matter of debate. Currently, the main therapies used in the treatment of COVID-19 are antiviral drugs and chloroquine/hydroxychloroquine. Other proposed options include tocilizumab, convalescent plasma, and steroids, but the mainstay of the treatment in intensive care units remains supportive therapies.

Cite this article as: Arıkan H, Karadoğan D, Tokgöz Akyıl F, et al. COVID-19 treatment at a glance. Turk Thorac J 2020; 21(6): 438-45.

Files
EISSN 2149-2530